PHT4;5 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PHT4;5 antibody; Os09g0556400 antibody; LOC_Os09g38410 antibody; Probable anion transporter 5 antibody; chloroplastic antibody; Phosphate transporter 4;5 antibody
Target Names
PHT4;5
Uniprot No.

Target Background

Function
This antibody targets PHT4;5, a protein that likely functions as an anion transporter.
Database Links
Protein Families
Major facilitator superfamily, Sodium/anion cotransporter (TC 2.A.1.14) family
Subcellular Location
Plastid, chloroplast membrane; Multi-pass membrane protein.

Q&A

What is PHT4;5 and what role does it play in plant systems?

PHT4;5 is a phosphate transporter protein found in Oryza sativa subsp. japonica (Rice) and other plant species. It belongs to the PHT4 family of phosphate transporters that play crucial roles in phosphate homeostasis within plant cells. In rice specifically, PHT4;5 is involved in intracellular phosphate compartmentalization and mobilization, which is essential for various metabolic processes and stress responses.

The antibody against PHT4;5 is a valuable research tool for investigating phosphate transport mechanisms in plants, particularly in rice. It allows researchers to detect, localize, and quantify PHT4;5 protein expression under various experimental conditions .

What are the optimal storage conditions for PHT4;5 antibody to maintain its functionality?

PHT4;5 antibody should be stored at -20°C or -80°C immediately upon receipt. Repeated freeze-thaw cycles should be strictly avoided as they can significantly degrade antibody quality and performance. For short-term storage (less than 1 month), aliquoting the antibody and storing at 4°C is acceptable, but long-term storage requires freezing conditions.

The antibody is typically prepared in a storage buffer containing 0.03% Proclin 300 as a preservative, 50% Glycerol, and 0.01M PBS at pH 7.4, which helps maintain stability during storage . For optimal preservation of antibody functionality:

  • Divide the antibody into small working aliquots before freezing

  • Thaw aliquots quickly at room temperature when needed for experiments

  • Avoid exposure to light, especially for conjugated antibodies

  • Always centrifuge briefly before opening vials to collect the solution at the bottom

What validation methods should be employed to confirm PHT4;5 antibody specificity?

Confirming antibody specificity is critical for reliable research results. For PHT4;5 antibody, a multi-step validation approach is recommended:

  • Western Blot Analysis: Perform Western blotting using plant tissue extracts, looking for a single band at the expected molecular weight of PHT4;5 protein (~50-55 kDa in rice). Include positive controls (rice samples) and negative controls (non-expressing tissues) .

  • Immunoprecipitation: Use the antibody to immunoprecipitate PHT4;5 from plant lysates, followed by mass spectrometry identification.

  • Immunofluorescence Comparison: Similar to validation methods used for other antibodies, compare staining patterns in expressing vs. non-expressing cells or tissues .

  • Knockout/Knockdown Validation: Compare antibody reactivity in wild-type samples versus samples where PHT4;5 has been knocked out or down via genetic approaches.

  • Peptide Competition Assay: Pre-incubate the antibody with excess immunizing peptide (recombinant Oryza sativa PHT4;5 protein) before application to samples; this should abolish specific signals .

What are the recommended working dilutions for PHT4;5 antibody in different applications?

Optimal working dilutions for PHT4;5 antibody vary by application:

ApplicationRecommended Dilution RangeOptimization Considerations
Western Blotting1:500 - 1:2,000Increase dilution for lower background
ELISA1:1,000 - 1:10,000Titrate to determine optimal signal-to-noise ratio
Immunofluorescence1:100 - 1:500Longer incubation may be needed for lower dilutions
Immunohistochemistry1:50 - 1:200Antigen retrieval method affects optimal dilution

Always perform titration experiments to determine the optimal dilution for your specific experimental conditions and tissue types. Start with manufacturer recommendations for the specific lot of antibody, as affinity can vary between production batches .

How can epitope mapping be performed to characterize the binding properties of PHT4;5 antibody?

Epitope mapping for PHT4;5 antibody requires a systematic approach to identify the specific amino acid sequence recognized by the antibody. Based on established techniques for conformational epitope mapping:

  • Overlapping Peptide Arrays: Synthesize overlapping peptides (15-20 amino acids) spanning the PHT4;5 sequence. Screen these peptides against the antibody using ELISA or peptide microarrays to identify reactive regions.

  • Alanine Scanning Mutagenesis: Introduce systematic alanine substitutions in the suspected epitope region of recombinant PHT4;5 protein. Test antibody binding to each mutant to identify critical residues for recognition.

  • Surface Plasmon Resonance (SPR): Use SPR to measure binding kinetics between the antibody and various PHT4;5 peptide fragments, similar to approaches that revealed picomolar affinity in other antibody studies .

  • Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS): This technique can identify regions of the protein that are protected from solvent exchange when bound to the antibody, revealing the epitope footprint.

  • X-ray Crystallography: For definitive epitope characterization, co-crystallize the PHT4;5 antibody with its target antigen or relevant peptide fragments and solve the structure.

This multi-technique approach can reveal whether the PHT4;5 antibody recognizes a linear or conformational epitope, which impacts its applications in different experimental contexts .

What strategies can be employed to minimize cross-reactivity when using PHT4;5 antibody in species other than Oryza sativa?

When using PHT4;5 antibody in non-rice plant species, cross-reactivity poses a significant challenge. To minimize this issue:

  • Sequence Homology Analysis: Perform bioinformatic analysis comparing PHT4;5 sequences across plant species to identify regions of high conservation and divergence.

  • Pre-adsorption Controls: Pre-incubate the antibody with extracts from non-target tissues to adsorb potentially cross-reactive antibodies.

  • Affinity Purification: Consider purifying the antibody against the specific PHT4;5 epitope from the species of interest using affinity chromatography.

  • Competitive Binding Assays: Design competitive binding assays using peptides from PHT4;5 orthologs to quantitatively assess cross-reactivity.

  • Gradient Antibody Concentration: Use a range of antibody concentrations to identify the optimal concentration that maximizes specific signal while minimizing cross-reactivity.

  • Longer Washing Steps: Implement more stringent washing protocols to remove weakly bound cross-reactive antibodies.

  • Western Blot Profile Analysis: Compare banding patterns across species to identify potential cross-reactive bands versus specific PHT4;5 signals.

These approaches should be validated experimentally for each new species to ensure reliable interpretation of results .

How do the functional characteristics of PHT4;5 polyclonal antibodies compare with monoclonal alternatives for phosphate transporter research?

The functional characteristics of polyclonal versus monoclonal antibodies for PHT4;5 research present important methodological considerations:

CharacteristicPHT4;5 Polyclonal AntibodyMonoclonal Alternative
Epitope CoverageRecognizes multiple epitopes on PHT4;5 proteinTargets single epitope with high specificity
SensitivityGenerally higher sensitivity due to multiple binding sitesMay have lower sensitivity but higher specificity
Batch-to-Batch VariabilityModerate to high variabilityLow variability after hybridoma establishment
Research ApplicationsExcellent for protein detection in Western blots and ELISASuperior for discriminating between closely related phosphate transporters
Functional EffectsLess likely to interfere with protein functionMay block functional domains depending on epitope
Production ScaleEasier to produce in large quantitiesRequires hybridoma technology but provides consistent results

For PHT4;5 research, polyclonal antibodies offer advantages in detecting low abundance transporters in plant tissues, while monoclonal antibodies would potentially provide more consistent results across experiments. The choice depends on the specific research question and experimental approach .

What are the methodological approaches for using PHT4;5 antibody to investigate phosphate transport mechanisms under stress conditions in plants?

Investigating phosphate transport mechanisms under stress conditions using PHT4;5 antibody requires multifaceted methodological approaches:

  • Time-Course Immunoblotting: Collect plant tissues at multiple time points after stress exposure (drought, salinity, nutrient deficiency) and quantify PHT4;5 protein levels using Western blotting with the PHT4;5 antibody. Normalization to stable reference proteins is crucial.

  • Subcellular Fractionation Combined with Immunodetection: Fractionate plant cells into different organelles and measure PHT4;5 localization changes using the antibody to track potential stress-induced relocalization.

  • Co-Immunoprecipitation Under Stress Conditions: Use PHT4;5 antibody to immunoprecipitate the transporter and its interacting partners under normal and stress conditions to identify stress-specific protein interactions.

  • Immunofluorescence Microscopy: Visualize changes in PHT4;5 localization pattern during stress using confocal microscopy and the antibody for immunolabeling.

  • Chromatin Immunoprecipitation (ChIP): If investigating transcriptional regulators of PHT4;5, use antibodies against candidate transcription factors combined with promoter analysis.

  • Correlative Analysis: Correlate PHT4;5 protein abundance (measured by antibody-based quantification) with physiological parameters and phosphate transport activity measurements.

  • Transgenic Approaches: Create plants with modified PHT4;5 expression and use the antibody to confirm protein levels in different experimental lines.

This integrated approach allows researchers to connect PHT4;5 protein dynamics directly to phosphate transport mechanisms under various stress conditions .

What controls should be included when using PHT4;5 antibody for immunolocalization studies?

A robust immunolocalization study using PHT4;5 antibody requires comprehensive controls:

  • Primary Antibody Controls:

    • Positive tissue control: Include known PHT4;5-expressing rice tissues

    • Negative tissue control: Include tissues where PHT4;5 is not expressed

    • Pre-immune serum control: Use serum from the same rabbit before immunization

    • Antibody dilution series: Test multiple antibody concentrations

  • Secondary Antibody Controls:

    • Secondary-only control: Omit primary antibody to assess non-specific binding

    • Isotype control: Use irrelevant rabbit IgG at the same concentration

    • Cross-reactivity control: Test secondary antibody against tissues without primary

  • Specificity Controls:

    • Peptide competition: Pre-incubate antibody with excess immunizing peptide

    • Knockout/knockdown validation: Use tissues with reduced PHT4;5 expression

    • Multiple antibody validation: If possible, compare localization with another PHT4;5 antibody raised against a different epitope

  • Technical Controls:

    • Autofluorescence control: Examine unstained samples to detect natural fluorescence

    • Fixation control: Compare different fixation methods for optimal epitope preservation

    • Signal amplification control: If using amplification systems, include appropriate enzyme controls

Document all controls clearly in methods sections when publishing results to ensure reproducibility and reliability of findings .

How can PHT4;5 antibody be used to investigate protein-protein interactions in phosphate transport complexes?

PHT4;5 antibody can be leveraged to investigate protein-protein interactions through several methodological approaches:

  • Co-Immunoprecipitation (Co-IP):

    • Use PHT4;5 antibody conjugated to beads to pull down PHT4;5 along with its interacting partners

    • Analyze the precipitated complexes by mass spectrometry to identify novel binding partners

    • Confirm interactions by reverse Co-IP using antibodies against the identified partners

    • Compare interaction profiles under different phosphate availability conditions

  • Proximity Ligation Assay (PLA):

    • Combine PHT4;5 antibody with antibodies against suspected interaction partners

    • PLA generates fluorescent signals only when proteins are in close proximity (<40 nm)

    • Quantify interaction frequency and localization in different cellular compartments

  • Bimolecular Fluorescence Complementation (BiFC) Validation:

    • After identifying candidate interactors, validate using BiFC

    • Use the antibody to confirm expression levels of fusion proteins

  • Blue Native PAGE:

    • Separate native protein complexes using non-denaturing conditions

    • Detect PHT4;5-containing complexes via Western blotting with the antibody

    • Identify complex components by mass spectrometry or sequential immunoblotting

  • Chemical Crosslinking Combined with Immunoprecipitation:

    • Crosslink proteins in their native state in plant tissues

    • Immunoprecipitate using PHT4;5 antibody

    • Identify crosslinked partners by mass spectrometry

    • Validate specific interactions using targeted approaches

These methods can reveal both stable and transient interactions of PHT4;5 with regulatory proteins and other transporters, providing insights into the functional organization of phosphate transport machinery .

What methodological modifications are needed when using PHT4;5 antibody for quantitative analysis of protein expression?

For quantitative analysis of PHT4;5 protein expression using its antibody, several methodological modifications are essential:

  • Sample Preparation Standardization:

    • Implement a standardized protein extraction protocol optimized for membrane proteins

    • Determine the linear range of detection for PHT4;5 by analyzing serial dilutions

    • Use phosphatase inhibitors during extraction to preserve phosphorylation states

  • Loading Control Selection:

    • Choose appropriate loading controls stable under your experimental conditions

    • For membrane proteins like PHT4;5, use membrane-specific controls (e.g., H+-ATPase)

    • Consider multiple loading controls for robust normalization

  • Quantification Method Optimization:

    • For Western blots: Use digital imaging systems with linear range detection

    • For ELISA: Develop a sandwich ELISA using PHT4;5 antibody as capture and detection antibody

    • For flow cytometry: Optimize permeabilization protocols for intracellular PHT4;5 detection

  • Standard Curve Implementation:

    • Generate standard curves using recombinant PHT4;5 protein

    • Include standard curve samples on each experimental blot/plate

    • Calculate absolute quantities based on standard curve analysis

  • Statistical Validation:

    • Run sufficient biological replicates (minimum n=3, preferably n≥5)

    • Perform technical replicates for each biological sample

    • Apply appropriate statistical tests for your experimental design

  • Control for Antibody Batch Variation:

    • Characterize each new antibody lot against a reference sample

    • Adjust quantification methods based on lot-specific sensitivity

  • Data Normalization Approaches:

    • Normalize to total protein using stain-free technology or reversible stains

    • Consider normalization to cell number or tissue weight for cross-sample comparison

    • Report data as fold-change relative to control and absolute values when possible

These modifications ensure reliable quantitative analysis of PHT4;5 expression across different experimental conditions .

How can PHT4;5 antibody be integrated into multi-omics approaches for understanding phosphate signaling networks?

Integrating PHT4;5 antibody into multi-omics research requires strategic experimental design:

  • Antibody-Based Proteomics:

    • Use PHT4;5 antibody for targeted proteomics via immunoprecipitation followed by mass spectrometry

    • Combine with phosphoproteomics to correlate PHT4;5 expression with phosphorylation cascades

    • Implement protein arrays using the antibody to detect PHT4;5 across multiple samples simultaneously

  • Integration with Transcriptomics:

    • Correlate PHT4;5 protein levels (detected via antibody) with transcript abundance

    • Identify post-transcriptional regulation by comparing mRNA:protein ratios

    • Use the antibody to isolate polysome-associated PHT4;5 mRNA for translatomics

  • Metabolomic Correlation:

    • Correlate PHT4;5 protein abundance with phosphate metabolite profiles

    • Identify metabolic signatures associated with altered PHT4;5 expression

    • Connect metabolite changes to PHT4;5 transport activity using antibody-based activity assays

  • Spatial Multi-Omics:

    • Use the antibody for spatial proteomics via imaging mass cytometry

    • Correlate spatial distribution of PHT4;5 with metabolite distribution

    • Implement single-cell approaches combining antibody detection with RNA sequencing

  • Network Analysis:

    • Use antibody-derived protein quantification data as nodes in signaling networks

    • Integrate with phosphorylation networks and transcriptional regulatory networks

    • Model PHT4;5-centered signaling hubs using quantitative antibody data

  • Temporal Dynamics:

    • Track PHT4;5 protein dynamics during stress responses using time-course antibody detection

    • Correlate with temporal transcriptome and metabolome changes

    • Develop predictive models incorporating antibody-quantified protein levels

This integrated approach provides a systems-level understanding of PHT4;5 function within broader phosphate signaling networks .

What are the strategies for resolving conflicting data between PHT4;5 antibody detection and transcript analysis?

When faced with discrepancies between PHT4;5 protein levels (detected via antibody) and mRNA expression, systematic investigation is required:

  • Verification of Technical Accuracy:

    • Confirm antibody specificity using knockout/knockdown controls

    • Validate RNA detection methods with alternative primers/probes

    • Examine potential cross-reactivity with closely related phosphate transporters

  • Post-Transcriptional Regulation Analysis:

    • Investigate microRNA targeting of PHT4;5 mRNA

    • Assess mRNA stability and half-life through actinomycin D chase experiments

    • Examine alternative splicing that might affect antibody recognition sites

  • Translational Efficiency Assessment:

    • Analyze polysome association of PHT4;5 mRNA

    • Investigate upstream open reading frames (uORFs) that might regulate translation

    • Examine translation efficiency under different phosphate conditions

  • Protein Stability Investigation:

    • Measure PHT4;5 protein half-life using cycloheximide chase experiments

    • Assess ubiquitination status using PHT4;5 immunoprecipitation followed by ubiquitin blotting

    • Examine proteasome-dependent vs. lysosomal degradation pathways

  • Temporal Dynamics Consideration:

    • Design time-course experiments to detect potential delays between transcription and translation

    • Sample at multiple time points to capture transient expression patterns

    • Consider circadian or diurnal regulation of both transcript and protein

  • Spatial Distribution Analysis:

    • Compare tissue-specific vs. whole-plant measurements

    • Examine subcellular localization and potential compartmentalization

    • Consider cell type-specific expression that might be diluted in bulk samples

  • Data Integration Approaches:

    • Use Bayesian networks to model the relationship between transcript and protein

    • Implement machine learning to identify patterns in discordant samples

    • Develop mathematical models accounting for synthesis and degradation rates

This systematic approach can reveal biological mechanisms explaining the discrepancy rather than dismissing it as technical artifact .

How can researchers distinguish between specific and non-specific signals when using PHT4;5 antibody in challenging plant tissues?

Distinguishing specific from non-specific signals requires rigorous methodological controls:

  • Pre-Adsorption Protocol:

    • Pre-incubate PHT4;5 antibody with excess immunizing peptide

    • Apply both pre-adsorbed and non-adsorbed antibody to adjacent tissue sections

    • Signals that disappear after pre-adsorption are likely specific

  • Signal Pattern Analysis:

    • Compare observed signal patterns with known subcellular localization of phosphate transporters

    • Non-specific signals often show random or ubiquitous distribution

    • Specific signals should align with expected biological localization

  • Antibody Titration Series:

    • Test multiple antibody concentrations to identify optimal signal-to-noise ratio

    • Plot signal intensity vs. antibody concentration for both target and control tissues

    • Specific signals typically show saturation kinetics

  • Alternative Detection Methods:

    • Compare results from multiple detection methods (Western blot, immunofluorescence, ELISA)

    • Consistent patterns across methods increase confidence in specificity

    • Divergent results suggest potential method-specific artifacts

  • Tissue-Specific Controls:

    • Include tissues with known high, low, and no expression of PHT4;5

    • Compare autofluorescence patterns in unstained tissues

    • Use tissues from PHT4;5 knockdown/knockout plants when available

  • Signal Quantification Approaches:

    • Implement digital image analysis with defined intensity thresholds

    • Use ratiometric measurements comparing signal to background

    • Apply spectral unmixing for multi-fluorophore experiments to reduce crosstalk

  • Technical Optimization:

    • Modify fixation protocols to preserve epitope accessibility

    • Optimize blocking solutions to reduce non-specific binding

    • Adjust washing stringency based on signal-to-noise ratio

  • Cross-Validation with Independent Methods:

    • Confirm protein expression using mass spectrometry

    • Validate localization with fluorescent protein fusions

    • Correlate with functional assays of phosphate transport

This comprehensive approach enables confident discrimination between specific PHT4;5 signals and non-specific background in challenging plant tissues .

What emerging technologies can enhance the application of PHT4;5 antibody in plant phosphate transport research?

Several cutting-edge technologies offer new possibilities for PHT4;5 antibody applications:

  • Single-Molecule Localization Microscopy:

    • Implement super-resolution techniques (STORM, PALM) using PHT4;5 antibody conjugated to photoswitchable fluorophores

    • Achieve nanoscale resolution of PHT4;5 distribution in membrane microdomains

    • Combine with other transporter antibodies for co-localization at molecular precision

  • Proximity-Dependent Biotinylation:

    • Fuse biotin ligase (BioID or TurboID) to nanobodies derived from PHT4;5 antibody

    • Map the proximal proteome of PHT4;5 in living plant cells

    • Identify transient interactions in their native cellular context

  • Antibody-Based Biosensors:

    • Develop FRET-based biosensors using PHT4;5 antibody fragments

    • Monitor conformational changes in PHT4;5 during transport cycles

    • Create real-time reporters of PHT4;5 activity in living tissues

  • Cryo-Electron Tomography:

    • Use antibody-gold labeling combined with cryo-ET

    • Visualize PHT4;5 in its native membrane environment

    • Determine structural organization of transport complexes at molecular resolution

  • Synthetic Biology Approaches:

    • Design synthetic antibody-based circuits that respond to PHT4;5 levels

    • Create conditionally activated systems for studying PHT4;5 function

    • Develop optogenetic tools for targeted manipulation of PHT4;5-containing complexes

  • Spatial Transcriptomics Integration:

    • Combine antibody-based protein detection with spatial transcriptomics

    • Map PHT4;5 protein-mRNA relationships with spatial resolution

    • Correlate with phosphate distribution using imaging mass spectrometry

  • High-Throughput Phenotyping Integration:

    • Develop antibody-based microarray approaches for screening PHT4;5 levels

    • Correlate with automated phenotyping of phosphate utilization efficiency

    • Implement machine learning for pattern recognition in complex datasets

These emerging technologies will significantly advance our understanding of PHT4;5 function in plant phosphate homeostasis and stress responses .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.